Application of Sterilization by Gamma Radiation for Single-Use Disposable Technologies in the Biopharmaceutical Sector - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Application of Sterilization by Gamma Radiation for Single-Use Disposable Technologies in the Biopharmaceutical Sector
This paper examines the process of gamma irradiation of plastic materials used as part of single-use disposable systems in the pharmaceutical and biotechnology sectors, with a focus on validation requirements.


Pharmaceutical Technology
Volume 36, Issue 5, pp. s20-s30


Understanding Gamma Sterilization, by Jerold Martin, Pall Life Sciences
Dose mapping. The third aspect of the validation is dose mapping. For this, the product, in its final packaging configuration, is profiled in order to identify the high and low zones of absorbed dose in the product load. Dose mapping determines the loading configuration that will be used during routine sterilization.

Validation parameters

The object of the validation is to set processing parameters and the product release specification. The validation parameters are established through a performance qualification (dose mappings), which is typically run three times using the maximum packaging size. The main steps for undertaking a performance qualification, for each product, are as follows:

  • Evaluate product and process suitability
  • Decide on the container presentation
  • Undertake dose mapping
  • Evaluate results
  • Establish release specification
  • Establish parameters for routine product sterilization.


FIgure 1
The level of radiation is assessed using devices called dosimeters (i.e., a device, instrument, or system that measures the exposure to radiation). It is important to assess the number of dosimeters required to assess the radiation dose. With a standard tote, it is typical to use 1520 dosimeters. This number is necessary in order to achieve an accurate assessment because the radiation dose applied to the products packaged at the outer edge of the tote is often higher than the dose received by the material in the inner center of the tote, as illustrated in Figure 1.

The key validation parameters are: product weight and volume, dimensions of packaging components and density, and the configuration of the packaging components. With the dimensions, it is important that the product is evenly distributed because the radiation dose is applied at the same level from both sides. With the issue of load configuration, this point is sometimes overlooked. It is nonetheless important that the way that the components are packaged during validation be replicated for all successive radiation runs. This is important because if the orientation alters, then this can cause changes to the density mix and thus the effectiveness of the irradiation. Once the validation parameters are established, the parameters are used for routine processing and no parameter should be permitted to vary significantly from the established parameter.

Once established, it is necessary that any future changes in product, its package, or the presentation of product for sterilization are re-assessed for the effect on the appropriateness of the sterilization process. It is prudent to re-assess the validation parameters at least on an annual basis and to assess the bioburden of the product quarterly, in order to determine that the gamma radiation process remains effective (27). This assessment may include fractional studies. Here the product is irradiated and tested at sublethal doses (i.e., at levels of gamma radiation below the minimum established in the validation study) to check for continued dose efficacy. This is sometimes referred to as dose auditing.

Gamma radiation process

On completion of the validation, the standard manufactured batches of the product can be subjected to routine sterilization. The sterilization process is based on the establishment of validation parameters.

To ensure good levels of quality control, it is recommended that the following steps be put in place:

  • Product and packaging description
  • Carrier loading configuration
  • Minimum allowable dose
  • Maximum allowable dose
  • Location of the dosimeter in the load
  • Specifications for temperature or humidity.

There are two methods of gamma radiation: continuous or batch. For both it is important that the distribution of gamma radiation applied to the product is even. With the continuous method, an automated conveyance system functions to move the product past a gamma source and back out on a continuous basis until the end of the cycle is achieved. With the batch methods, a set number of totes are used at set positions within the irradiation chamber. Special chemical indicator labels should be fixed to each item to indicate if irradiation has been successful. The radioisotope is then moved into an exposure position, and the product is irradiated for a specified period of time. The method selected is dependent upon the method used during the validation.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here